Piperidine-1,4-dicarboxylic acid 1-benzyl ester 4-methyl ester, 95.0%, 100g

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging

2-(1H-INDAZOL-6-YLTHIO)-N-METHYL-BENZAMIDE, 95.0%, 250mg

ethyl 5-hydroxy-3-methylisoxazole-4-carboxylate, 100mg

3-Bromophenylmethylsulfone, 98.0%, 25g

HPLC bottle with multiple distributor, HPLC bottle 1000 ml, 2 Piece(s)

5-Amino-2-chloropyridine>98.0%(GC)(T)1g

Ethyl 4-amino-2-hydroxypyrimidine-5-carboxylate, 95.0%, 100mg

Ethyl 5-(4-n-Propylphenyl)-5-oxovalerate, 97.0%, 250mg

2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-5-(trifluoromethyl)benzonitrile, 95%, 250mg

(1R,4S)-Dimethyl 1-((R)-1-(phenylamino)-2-(p-tolyl)ethyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate, 98.00%, 25mg

5-(Tert-butoxycarbonyl)thiophene-2-carboxylic acid, 98%, 100mg

1-Methyl-3-n-octylimidazolium Bromide>98.0%(HPLC)5g